| 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 化学原料药(元) | - | - | - | 1,547,528,345.16 |
| 制剂(元) | 3,985,519,069.87 | 2,057,915,530.85 | 4,072,208,527.22 | 2,261,818,403.94 |
| 医药中间体及其他(元) | 2,123,617,162.42 | 1,091,517,056.20 | 1,658,147,073.11 | 923,134,718.14 |
| 解热镇痛类原料药(元) | 2,645,585,755.49 | 1,489,371,455.93 | 2,735,954,202.75 | - |
| 营业成本(元) | ||||
| 化学原料药(元) | - | - | - | 1,000,611,722.71 |
| 制剂(元) | 3,345,883,204.61 | 1,676,918,880.50 | 3,002,579,189.52 | 1,645,196,746.51 |
| 医药中间体及其他(元) | 2,063,459,012.58 | 1,094,898,797.25 | 1,633,231,346.54 | 902,123,336.02 |
| 解热镇痛类原料药(元) | 1,700,837,409.54 | 937,447,707.60 | 1,788,950,185.65 | - |
| 毛利(元) | ||||
| 化学原料药(元) | - | - | - | 546,916,622.45 |
| 制剂(元) | 639,635,865.26 | 380,996,650.35 | 1,069,629,337.70 | 616,621,657.43 |
| 医药中间体及其他(元) | 60,158,149.84 | -3,381,741.05 | 24,915,726.57 | 21,011,382.12 |
| 解热镇痛类原料药(元) | 944,748,345.95 | 551,923,748.33 | 947,004,017.10 | - |
| 毛利率(%) | ||||
| 化学原料药(%) | - | - | - | 35.34 |
| 制剂(%) | 16.05 | 18.51 | 26.27 | 27.26 |
| 医药中间体及其他(%) | 2.83 | -0.31 | 1.50 | 2.28 |
| 解热镇痛类原料药(%) | 35.71 | 37.06 | 34.61 | - |
| 收入构成(%) | ||||
| 化学原料药(%) | - | - | - | 32.70 |
| 制剂(%) | 45.52 | 44.36 | 48.10 | 47.79 |
| 医药中间体及其他(%) | 24.26 | 23.53 | 19.59 | 19.51 |
| 解热镇痛类原料药(%) | 30.22 | 32.11 | 32.32 | - |
| 毛利构成(%) | ||||
| 化学原料药(%) | - | - | - | 46.17 |
| 制剂(%) | 38.89 | 40.99 | 52.39 | 52.06 |
| 医药中间体及其他(%) | 3.66 | -0.36 | 1.22 | 1.77 |
| 解热镇痛类原料药(%) | 57.45 | 59.38 | 46.39 | - |